PMCTPharmaCountry
    Home

DARZALEX 20 mg/mL, solution à diluer pour perfusion

JC
JANSSEN CILAG INTERNATIONAL NV
Marketing & Commercial Services Provider · Contract & Outsourcing ServicesFlag of FRFrance
Rx

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Other/Unclassified Dosage Forms / Other Unclassified Dosage Forms

Trade Type

Sell

Product Name

DARZALEX 20 mg/mL, solution à diluer pour perfusion

Details

DARATUMUMAB 20 mg

Substance

Daratumumab

Registered Market

Specifications

  • Dosage Form: Concentrate for solution
  • Packaging: 1 bottle(s) in glass of 5 ml • 1 bottle(s) in glass of 20 ml

Documents

Drug Marketing Authorization Number
Document No.: 67352140
Issue Date: May 20, 2016
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Explore More

Similar Products & Services

Products & Services related to what you're viewing

Explore More

People Also Viewed

Other products & services viewed by people who looked at this product

Discover More